Hilton Head Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
3,927
+69
+2% +$23.6K 0.72% 33
2026
Q1
$1.36M Buy
3,858
+60
+2% +$21.4K 0.77% 30
2025
Q4
$1.24M Buy
+3,798
New +$1.2M 0.73% 28

Other funds holding AMGN

Hilton Head Capital Partners's AMGN Position: Q2 2026 in Review

Hilton Head Capital Partners increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $23.6K and bringing the position to 3,927 shares worth $1.42M. The position accounts for 0.72% of the portfolio, ranked #33.

Hilton Head Capital Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hilton Head Capital Partners held 3,927 shares of Amgen worth $1.42M as of Q2 2026.
  • Hilton Head Capital Partners bought 69 Amgen shares in Q2 2026, an estimated $23.6K.
  • Amgen made up 0.72% of Hilton Head Capital Partners's portfolio in Q2 2026, its #33 holding.
  • Hilton Head Capital Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.